Mineralocorticoid receptor activation and oxidative stress.
Funder
John W
JW
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use; D004195:Disease Models, Animal; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000235:genetics / Q000378:metabolism*; D007674:Kidney Diseases / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism*; D024821:Metabolic Syndrome / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D018384:Oxidative Stress / Q000235:genetics; D051381:Rats; D011918:Rats, Inbred SHR; D011956:Receptors, Cell Surface / Q000172:deficiency / Q000235:genetics; D054411:Receptors, Leptin; D018161:Receptors, Mineralocorticoid / Q000378:metabolism*; D017673:Sodium Chloride, Dietary
D000975:Antioxidants; D000451:Mineralocorticoid Receptor Antagonists; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin; D018161:Receptors, Mineralocorticoid; D017673:Sodium Chloride, Dietary